These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 10947396)

  • 21. High-dose chemotherapy for breast cancer.
    Gratwohl A; Baldomero H; Rosti G
    Bone Marrow Transplant; 2000 Sep; 26(6):599. PubMed ID: 11041563
    [No Abstract]   [Full Text] [Related]  

  • 22. [High dose chemotherapy versus conventional chemotherapy in metastasing breast cancer. An analysis of a systematic Cochrane review].
    Nielsen DL; Svane IM
    Ugeskr Laeger; 2004 Nov; 166(46):4145-7. PubMed ID: 15565848
    [No Abstract]   [Full Text] [Related]  

  • 23. Perspectives. Indefinite results in ABMT (autologous bone marrow transplantation) trials add to challenges for practice standards, quality assurance in cancer care.
    Cunningham R
    Med Health; 1999 Apr; 53(16):suppl 1-4. PubMed ID: 10387749
    [No Abstract]   [Full Text] [Related]  

  • 24. Dose intensive therapy in breast cancer.
    Antman K; Corringham R; de Vries E; Elfenbein G; Gianni AM; Gisselbrecht C; Herzig R; Juttner C; Kaizer H; Kennedy MJ
    Bone Marrow Transplant; 1992; 10 Suppl 1():67-73. PubMed ID: 1355686
    [No Abstract]   [Full Text] [Related]  

  • 25. Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients.
    Kröger N; Damon L; Zander AR; Wandt H; Derigs G; Ferrante P; Demirer T; Rosti G; ; ;
    Bone Marrow Transplant; 2003 Dec; 32(12):1153-7. PubMed ID: 14647269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of cancer with high-dose chemotherapy and autologous stem cell transplantation].
    Geisler CH; Daugaard KG; Dickmeiss E; Ifversen M; Knudsen LM
    Ugeskr Laeger; 2003 Dec; 165(50):4846-9. PubMed ID: 14716902
    [No Abstract]   [Full Text] [Related]  

  • 27. [Up-to-date treatment of breast cancer. Myeloblastic chemotherapy and hematopoietic cell grafting].
    Jerusalem G
    Rev Med Liege; 1997 Feb; 52(2):76-9. PubMed ID: 9173487
    [No Abstract]   [Full Text] [Related]  

  • 28. End of high-dose chemotherapy for high-risk breast cancer patients?
    Tuma RS
    J Natl Cancer Inst; 2008 May; 100(9):618-9. PubMed ID: 18445811
    [No Abstract]   [Full Text] [Related]  

  • 29. High-dose chemotherapy for malignancies: a review.
    Roman-Unfer S; Bitran JD
    Compr Ther; 1996 Feb; 22(2):107-20. PubMed ID: 8689864
    [No Abstract]   [Full Text] [Related]  

  • 30. Experimental medical treatments: who should decide coverage?
    Collins JC
    Seattle Univ Law Rev; 1997; 20(2):451-87. PubMed ID: 16528856
    [No Abstract]   [Full Text] [Related]  

  • 31. The controversy over high-dose chemotherapy with autologous bone marrow transplant for breast cancer.
    Mello MM; Brennan TA
    Health Aff (Millwood); 2001; 20(5):101-17. PubMed ID: 11558695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variations in insurance coverage for autologous bone marrow transplantation for breast cancer.
    Khanna V
    N Engl J Med; 1994 Aug; 331(5):330-1. PubMed ID: 8022453
    [No Abstract]   [Full Text] [Related]  

  • 33. Variations in insurance coverage for autologous bone marrow transplantation for breast cancer.
    Erban JK
    N Engl J Med; 1994 Aug; 331(5):330; author reply 330-1. PubMed ID: 8022450
    [No Abstract]   [Full Text] [Related]  

  • 34. Is high-dose chemotherapy with autologous hematopoietic stem cell transplantation in breast cancer patients a done deal?
    Cheng YC; Ueno NT
    Womens Health (Lond); 2010 Jul; 6(4):481-5. PubMed ID: 20597609
    [No Abstract]   [Full Text] [Related]  

  • 35. Adjuvant treatment of high-risk stage II breast cancer with doxorubicin followed by high-dose chemotherapy and autologous stem-cell transplantation: a single-institution experience with 132 consecutive patients.
    Stemmer SM; Hardan I; Raz H; Adamou AK; Inbar M; Gottfried M; Merrick Y; Cohen Y; Sulkes A; Ben-Baruch N; Pfeffer RP; Brenner HJ; Rizel S
    Bone Marrow Transplant; 2003 Apr; 31(8):655-61. PubMed ID: 12692605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A new path for research in childhood cancer: high-dose chemotherapy with bone-marrow autograft].
    Lemerle J; Hartmann O
    Soins Gynecol Obstet Pueric Pediatr; 1984; (39-40):66. PubMed ID: 6393405
    [No Abstract]   [Full Text] [Related]  

  • 37. [Intensive regional chemotherapy of certain cancers under protection of autologous bone marrow transfusion].
    Redon H; Dupas M; Fasano JJ; Singier JR; Nataf
    Presse Med (1893); 1966 Nov; 74(51):2619-20. PubMed ID: 5332939
    [No Abstract]   [Full Text] [Related]  

  • 38. [Massive chemotherapy and bone marrow autografts in solid tumors and non-leukemic lymphomas in pediatrics].
    Philip T; Bouffet E; Biron P; Philip I; Brunat-Mentigny M
    Ann Pediatr (Paris); 1984 Oct; 31(9):745-52. PubMed ID: 6395777
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluating promising new treatments for life-threatening disease: implications of the HDC/ABMT experience for treating breast cancer.
    Edwards S
    Find Brief; 2005 Jan; 8(1):1-3. PubMed ID: 15672527
    [No Abstract]   [Full Text] [Related]  

  • 40. No place for politics.
    Fee K
    Mod Healthc; 2000 May; 30(21):48, 50. PubMed ID: 11067549
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.